Valuation: Advanced Enzyme Technologies Limited

Capitalization 33.62B 371M 314M 286M 274M 506M 525M 3.34B 1.32B 16.22B 1.39B 1.36B 56.97B P/E ratio 2026 *
22.1x
P/E ratio 2027 * 19.4x
Enterprise value 33.62B 371M 314M 286M 274M 506M 525M 3.34B 1.32B 16.22B 1.39B 1.36B 56.97B EV / Sales 2026 *
4.6x
EV / Sales 2027 * 3.94x
Free-Float
44.14%
Yield 2026 *
1.83%
Yield 2027 * 2.06%
1 day-0.99%
1 week-3.49%
Current month+1.20%
1 month+9.00%
3 months-9.10%
6 months-2.83%
Current year-0.63%
1 week 293.4
Extreme 293.4
310.8
1 month 259
Extreme 259
318
Current year 259
Extreme 259
318
1 year 257.9
Extreme 257.9
366.25
3 years 225
Extreme 225
571
5 years 225
Extreme 225
571
10 years 98.1
Extreme 98.1
571
Manager TitleAgeSince
Director of Finance/CFO 61 2002-08-31
Compliance Officer - 2017-02-13
Corporate Officer/Principal 53 2005-02-28
Director TitleAgeSince
Director/Board Member 53 2014-12-07
Chairman 86 2017-03-24
Director/Board Member 56 2016-12-13
Change 5d. change 1-year change 3-years change Capi.($)
-0.99%-3.49%+2.11%+9.90% 375M
-0.05%+0.20%+14.25%+92.27% 86.05B
-2.13%-2.99%-25.16%+5.06% 36.48B
-0.91%-3.27%-36.44%-45.00% 31.99B
+1.94%+3.11%-2.18%+47.44% 24.21B
+0.33%-2.62%+89.32%-12.91% 20.68B
+2.01%-1.76%+106.20%-28.77% 19.91B
-0.36%-2.35%-4.88%-12.61% 18.95B
+0.98%-0.82%+24.23%+115.44% 15.7B
-1.54%+1.36%+66.79%+0.22% 13.79B
Average -0.10%-0.36%+23.42%+17.10% 26.81B
Weighted average by Cap. -0.15%-0.18%+15.89%+31.98%

Financials

2026 *2027 *
Net sales 7.3B 80.58M 68.13M 62.22M 59.56M 110M 114M 726M 287M 3.52B 302M 296M 12.38B 8.54B 94.16M 79.61M 72.7M 69.6M 129M 133M 848M 336M 4.12B 353M 346M 14.46B
Net income 1.52B 16.81M 14.22M 12.98M 12.43M 22.96M 23.8M 151M 59.97M 735M 63.06M 61.76M 2.58B 1.73B 19.07M 16.13M 14.73M 14.1M 26.05M 27M 172M 68.04M 834M 71.54M 70.06M 2.93B
Net Debt - -
Logo Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited is an India-based company, engaged in manufacturing enzymes and probiotics. The Company is focused on the research and development, manufacturing, and marketing of approximately 400 products, which is developed from over 68 indigenous enzymes and probiotics. It provides solutions to various industries, such as human health care and nutrition, animal nutrition, baking, fruit, and vegetable processing, brewing, and malting, grain processing, protein modification, dairy processing, textile processing, and others. It offers products and solutions for human nutrition, which include serratiopeptidase, fungal lactase, fungal lipase, and papain; animal nutrition, which include DigeGrain X, DigeGrain XL and DigeGrain M; food processing, including dairy and cheese processing and yeast processing, and non-food processing, including textiles processing, leather, and biofuels. Its oils and fats processing include oil extraction, oil refining, and others.
Employees
338
Date Price Change Volume
26-02-18 300.35 -0.99% 68,356
26-02-17 303.35 +2.16% 174,457
26-02-16 296.95 -1.33% 53,808
26-02-13 300.95 -1.68% 68,158
26-02-12 306.10 -1.64% 58,749
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
303.35INR
Average target price
370.00INR
Spread / Average Target
+21.97%

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ADVENZYMES Stock